F. Negro

1.3k total citations
43 papers, 969 citations indexed

About

F. Negro is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, F. Negro has authored 43 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 25 papers in Epidemiology and 5 papers in Rheumatology. Recurrent topics in F. Negro's work include Hepatitis C virus research (27 papers), Liver Disease Diagnosis and Treatment (17 papers) and Hepatitis B Virus Studies (15 papers). F. Negro is often cited by papers focused on Hepatitis C virus research (27 papers), Liver Disease Diagnosis and Treatment (17 papers) and Hepatitis B Virus Studies (15 papers). F. Negro collaborates with scholars based in Italy, Switzerland and United States. F. Negro's co-authors include Ilia Leviev, Richard W. James, Mario Rizzetto, Saeed Hamid, Paola Cassoni, Anna Sapino, Laura Rubbia‐Brandt, Paolo Fabris, L. Bozzola and S. Paganin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

F. Negro

40 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Negro Italy	13	589	589	127	95	79	43	969
Béla Hunyady Hungary	14	302 0.5×	225 0.4×	15 0.1×	6 0.1×	149 1.9×	58	695
Michael D. Josephs United States	11	181 0.3×	120 0.2×	6 0.0×	7 0.1×	212 2.7×	20	669
Joo Chun Yoon South Korea	12	377 0.6×	414 0.7×	8 0.1×	5 0.1×	255 3.2×	19	984
André Gauthier France	11	173 0.3×	160 0.3×	37 0.3×	2 0.0×	194 2.5×	16	705
Satomi Hashimoto Japan	12	100 0.2×	39 0.1×	12 0.1×	6 0.1×	217 2.7×	25	545
S Sitaraman United States	5	288 0.5×	281 0.5×	6 0.0×	2 0.0×	200 2.5×	6	793
Matthias Schulz Germany	11	181 0.3×	221 0.4×	14 0.1×		53 0.7×	18	620
Jeong‐Min Hong South Korea	10	175 0.3×	53 0.1×	29 0.2×		179 2.3×	19	525
M Wettstein Germany	14	155 0.3×	136 0.2×	52 0.4×	1 0.0×	204 2.6×	27	728
James H. Zavecz United States	16	71 0.1×	64 0.1×	6 0.0×	10 0.1×	184 2.3×	34	574

Countries citing papers authored by F. Negro

Since Specialization

Citations

This map shows the geographic impact of F. Negro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Negro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Negro more than expected).

Fields of papers citing papers by F. Negro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Negro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Negro. The network helps show where F. Negro may publish in the future.

Co-authorship network of co-authors of F. Negro

This figure shows the co-authorship network connecting the top 25 collaborators of F. Negro. A scholar is included among the top collaborators of F. Negro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Negro. F. Negro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rizzetto, Mario, Saeed Hamid, & F. Negro. (2021). The changing context of hepatitis D. Journal of Hepatology. 74(5). 1200–1211. 107 indexed citations

Bruggmann, Philip, Sarah Blach, Pierre Deltenre, et al.. (2017). Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. Swiss Medical Weekly. 147(4546). w14543–w14543. 13 indexed citations

Sobolewski, Cyril, et al.. (2016). Hepatitis C Virus Core Protein of Genotype 3A Downregulates PTEN Expression in Hepatocytes through Micrornas-Dependent Mechanisms. Journal of Hepatology. 64(2). S423–S423.

Negro, F.. (2014). Hepatitis D Virus Coinfection and Superinfection. Cold Spring Harbor Perspectives in Medicine. 4(11). a021550–a021550. 99 indexed citations

Morard, Isabelle, Sophie Clément, Alexandra Calmy, et al.. (2014). Clinical Significance of the CCR5delta32 Allele in Hepatitis C. PLoS ONE. 9(9). e106424–e106424. 8 indexed citations

Girardin, François, Youssef Daali, Marianne Gex‐Fabry, et al.. (2012). Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection. Journal of Viral Hepatitis. 19(8). 568–573. 18 indexed citations

Younossi, Zobair M., et al.. (2012). 936 LOW SERUM FERRITIN IS AN INDEPENDENT PREDICTOR OF HEPATITIS C VIRUS (HCV) CLEARANCE: A POPULATION-BASED STUDY. Journal of Hepatology. 56. S365–S365. 1 indexed citations

Rau, Monika, Marc G. Weisskopf, Felix Stickel, et al.. (2012). 1152IMPACT OF GENETIC CONCENTRATIVE NUCLEOSIDE TRANSPORTER VARIANTS ON PEG-INTERFERON/RIBAVIRIN THERAPY RESPONSE AND RIBAVIRIN SERUM LEVELS IN HEPATITIS C PATIENTS. Journal of Hepatology. 56. S455–S456. 4 indexed citations

Negro, F.. (2011). Management of chronic hepatitis B: an update. Swiss Medical Weekly. 141(3738). w13264–w13264. 5 indexed citations

10.

Cristofori, Chiara, Gianluca Svegliati‐Baroni, Michela Pasino, et al.. (2011). P.1.111: POST LOAD INSULIN RESISTANCE IS NOT A PREDICTOR OF SUSTAINED VIROLOGIC RESPONSE IN CHRONIC HEPATITIS C PATIENTS RECEIVING PEG-INTERFERON PLUS RIBAVIRIN. Digestive and Liver Disease. 43. S185–S185. 1 indexed citations

11.

Lagging, Martin, Galia Askarieh, Pierre–Yves Bochud, et al.. (2010). Ip-10 Is Associated With Il28b Variation And Predicts The First Phase Decline Of Hcv Rna And Outcome Of Therapy In Chronic Hepatitis C. IRIS. 2 indexed citations

12.

Bihl, Florian & F. Negro. (2010). Hepatitis E virus: a zoonosis adapting to humans. Journal of Antimicrobial Chemotherapy. 65(5). 817–821. 30 indexed citations

13.

Morard, Isabelle, Markus H. Heim, Jean‐François Dufour, et al.. (2008). Pegylated interferon‐alpha_2a/ribavirin treatment of recurrent hepatitis C after liver transplantation. Transplant Infectious Disease. 11(1). 33–39. 16 indexed citations

14.

Rolnik, Benjamin, et al.. (2007). SF-36 quality of life questionaire evaluation in a large cohort of women with breast cancer treated with hormonotherapy. Journal of Clinical Oncology. 25(18_suppl). 19657–19657. 1 indexed citations

15.

Negro, F. & A. Hadengue. (2006). Prise en charge de l'hépatite B chronique. Forum Médical Suisse ‒ Swiss Medical Forum. 6(42). 1 indexed citations

16.

Rubbia‐Brandt, Laura, Paolo Fabris, S. Paganin, et al.. (2004). Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut. 53(3). 406–412. 229 indexed citations

17.

Negro, F., Mauro Papotti, Stefano Taraglio, et al.. (1997). Relationship between hepatocyte proliferation and hepatitis delta virus replication in neoplastic and non‐neoplastic liver tissues. Journal of Viral Hepatitis. 4(2). 93–98. 6 indexed citations

18.

Leviev, Ilia, F. Negro, & Richard W. James. (1997). Two Alleles of the Human Paraoxonase Gene Produce Different Amounts of mRNA. Arteriosclerosis Thrombosis and Vascular Biology. 17(11). 2935–2939. 147 indexed citations

19.

Cassoni, Paola, Anna Sapino, F. Negro, & G Bussolati. (1994). Oxytocin inhibits proliferation of human breast cancer cell lines. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 425(5). 467–72. 77 indexed citations

20.

Paradisi, L, et al.. (1984). Behaviour of cyclic nucleotides and Ca²⁺ levels in liver tissue of rats poisoned by white phosphorus and trichlorobromomethane. Cell Biochemistry and Function. 2(2). 111–114. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact